tirzepatide effects on pancreas does affect your Comparative safety and side of semaglutide and tirzepatide: Implications for GLP-1 Agonists and Pancreatitis Risk

Purpose of Review To discuss current literature and provide practical recommendations for the safe and effective use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) in people with inflammatory bowel disease (IBD) and type 2 diabetes (T2D) and/or obesity

A large cohort study finds GLP-1 receptor agonists linked to lower graft loss and mortality in kidney transplant recipients with diabetes, supporting further clinical trials.

That's 35% more weight lossand the benefits extended beyond the scale

Do you see real access improving

Semaglutide (Ozempic) and tirzepatide (Mounjaro) available via telehealth across Alaska

Covers shelf life, half-life, degradation signs, and storage protocols.